Ncardia's Series B Round

Ncardia raised a round of funding on November 17, 2017.

Ncardia is an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its human induced pluripotent stem cell (iPSC)-deri…

Articles about Ncardia's Series B Round: